The iRGD is a tumor-penetrating peptide that binds to αvβ3/αvβ5 integrins and is cleaved to expose a CendR motif, which interacts with neuropilin-1 (NRP-1) to enhance tissue penetration, including BBB crossing [164]. This evidence concerns the gene NRP1 and neoplasm.